Publications by authors named "Christopher Maisel"

Claim this Profile
P
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Christopher Maisel

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Paul G Richardson, Albert Oriol, Alessandra Larocca, Joan Bladé, Michele Cavo, Christopher Maisel

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous presentation of two distinct plasma cell neoplasms.
David M Metter, Christopher Maisel, John R Krause

Proc (Bayl Univ Med Cent)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph⁺ pre-B acute lymphoblastic leukaemia.
Sara Robinson, Yair Levy, Christopher Maisel, Alex W Tong

BMJ Case Rep· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
Edward Agura, Barry Cooper, Houston Holmes, Estil Vance, Robert Brian Berryman, Christopher Maisel

Oncologist· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
Eric D Batts, Christopher Maisel, Donna Kane, Lili Liu, Pingfu Fu

Cancer Chemother Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis